Research Article

Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk

Figure 3

Scatter plots with linear regression fit for the relationship between GABA and glutamate+glutamine (Glx) levels among patients with first-episode schizophrenia (FES, , ), subjects at ultrahigh risk for psychosis (UHR, , ), and healthy controls (HC, , ).